Crop science giant Bayer says it has settled 17,000 glyphosate cases so far and hopes for a supreme court ruling next year.

The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...

Bayer has recently settled thousands of cases over claims the active ingredient in its Roundup weedkiller causes cancer, ...

Heading into the second half of their 2025 financial year, Bayer leaders echo positive comments surrounding the company’s ...

Bayer’s Roundup pesticide is linked with cancer. Its fight to dodge accountability threatens to leave sick people holding the ...

The company is streamlining its global workforce as part of a multi-year cost-cutting strategy, while raising its 2025 ...

Glyphosate, a key product that is used by a number of farmers, could be coming to an end. Bill Anderson, the CEO of Bayer, ...

Bayer, the biotech company and manufacturer of Round Up, has substantially increased its spending on lobbying in Iowa since ...

BAYRY beats on Q2 earnings and raises 2025 sales outlook (on a currency-adjusted basis) as pharma growth offsets currency and ...

Bayer has cut more than one in 10 jobs since the launch of a sweeping restructuring programme aimed at streamlining decision-making and reducing layers of management.

PROFIT FORECAST: The German pharmaceutical and agricultural conglomerate pre-released preliminary second-quarter numbers last week, announcing group earnings before interest, tax, depreciation, ...

Bayer said on Wednesday it had cut about 12,000 full-time positions since the start of a restructuring programme to speed up ...